Comprehensive overview: efficacy, tolerability, and cost-effectiveness of clobazam in Lennox–Gastaut syndrome
Michele A Faulkner1,21Department of Pharmacy Practice, Creighton University School of Pharmacy, 2Department of Neurology, Creighton University School of Medicine, Omaha, NE, USAAbstract: Clobazam is the newest medication approved by the US Food and Drug Administration (FDA) for the...
保存先:
| 第一著者: | |
|---|---|
| フォーマット: | 図書 |
| 出版事項: |
Dove Medical Press,
2015-06-01T00:00:00Z.
|
| 主題: | |
| オンライン･アクセス: | Connect to this object online. |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|
インターネット
Connect to this object online.3rd Floor Main Library
| 請求記号: |
A1234.567 |
|---|---|
| 所蔵 1 | 利用可 |